News Focus
News Focus
icon url

Amatuer17

03/23/18 3:49 PM

#198 RE: Phoenix300 #197

The space is good - the technology in pre-clinical - 9 to 10 months from starting 1st clinical trial

200 million o/s shares mean - around $75-80 million market cap - higher than one would expect

Unless someone in desperation to enter CNS area goes for BO - this will remain here or lower

Look at TNXP - it has PTSD drug in P3 trial - interim readout in Q3 - still market cap 24 million

That is a good near term gamble compared to this
icon url

noretreat

03/23/18 4:34 PM

#199 RE: Phoenix300 #197

that is the million dollar question. seems to be fairly stable at this level for now.